Thyroid Eye Disease clinical trials at University of California Health
1 research study open to eligible people
open to eligible people ages 18 years and up
The overall objective is to investigate the efficacy, safety and tolerability of TEPEZZA® in participants with chronic (inactive) TED (thyroid eye disease). Approximately 57 participants will be enrolled. There will be a treatment period (through Week 24) and a follow up period (where TEPEZZA will not be infused).